The new report by Expert Market Research titled, ‘Global Radiopharmaceuticals Market Size, Share, Trends, Growth, Scope, Report and Forecast 2023-2031’, gives an in-depth analysis of the global radiopharmaceuticals market, assessing the radiopharmaceuticals market based on its segments like generator types, applications, end uses, and major regions.

The report tracks the latest trends in the industry and studies their impact on the overall market. It also assesses the market dynamics, covering the key demand and price indicators, along withanalyzingthe market based on the SWOT and Porter’s Five Forces models.

The key highlights of the report include:

Market Overview (2018-2031)

  • Historical Market Size (2022): USD 5 billion
  • Forecast CAGR (2023-2031): 7.50%
  • Forecast Market Size (2031): USD 9.53 billion

The growing market of radiopharmaceuticals is being led by a significant share held by North America. This can be ascribed to the presence of leading market players and well-funded research facilities in the region. With regular advances in the healthcare sector, the region is likely to maintain dominance in the coming years as well. Further, on the basis of region, the Asia Pacific region is anticipated to grow at a significant pace during the forecast period.

Request a free sample copy in PDF or view the report summary@

Furthermore, owing to the commonality of thyroid-related disorders, the SPECT segment among the diagnostic radiopharmaceuticals is anticipated to propel the market during the forecast period. Moreover, with the year-by-year rise in cancer patients, the oncology segment is expected to witness significant growth in the coming years, thereby contributing to the market growth.

Radiopharmaceuticals Industry Definition and Segmentation

A radiopharmaceutical is defined as a group of pharmaceutical drugs that contains radioisotopes. Also known as medicinal radiocompounds, radiopharmaceuticals can be used as a diagnosis medication as well as a therapeutic agent for both chronic and critical diseases.

Explore the full report with the table of contents@

Based on generators type, the market can be segmented into:

  • W-188/Re-188 Generators
  • Mo-99/Tc-99m Generators
  • Sr-82/Rb-82 Generators
  • Sr-90/Y-90 Generators
  • Ge-68/Ga-67,68 Generators

On the basis application, the market can be divided into:

  • Diagnostic Radiopharmaceuticals
  • SPECT (Single-Photon Emission Computed Tomography)
  • PET (Positron Emission Tomography)
  • Therapeutic Radiopharmaceuticals
  • Oncology
  • Cardiology and Neurology
  • Theranostics

The major end use segments of radiopharmaceuticals are:

  • Hospitals
  • Diagnostic Centres

The regional markets for radiopharmaceuticals include:

  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • Middle East and Africa

Radiopharmaceuticals Market Trends

The radiopharmaceutical segment is the fastest-growing segment of the overall pharmaceutical industry. This can be associated with the rising demand for timely diagnostics and treatment of diseases owing to the increasing prevalence of chronic and fatal disorders. As a result, the revolutionary utilisation of radiopharmaceuticals in diagnostics is gaining popularity in the healthcare sector.

Furthermore, the rising acceptance of disease-specific therapy, enhanced patient awareness regarding accurate and timely diagnosis, and expanding applications of molecular imaging are additional factors invigorating the growth of radiopharmaceuticals.

Key Market Players

The major players in the market are Jubilant Pharma Holdings Inc., Clarity Pharmaceuticals, and Cardinal Health, among others.

The report covers the market shares, capacities, plant turnarounds, expansions, investments and mergers and acquisitions, among other latest developments of these market players.

Read More Reports :

South Korea Sugar Free Beverages Market:

Image Recognition Market:

Semiochemicals Market:

LED Lighting Market:

Metamaterial Market:

About Us :

Expert Market Research (EMR) is leading market research company with clients across the globe. Through comprehensive data collection and skilful analysis and interpretation of data, the company offers its clients extensive, latest and actionable market intelligence which enables them to make informed and intelligent decisions and strengthen their position in the market. The clientele ranges from Fortune 1000 companies to small and medium scale enterprises.

EMR customises syndicated reports according to clients’ requirements and expectations. The company is active across over 15 prominent industry domains, including food and beverages, chemicals and materials, technology and media, consumer goods, packaging, agriculture, and pharmaceuticals, among others.

Over 3000 EMR consultants and more than 100 analysts work very hard to ensure that clients get only the most updated, relevant, accurate and actionable industry intelligence so that they may formulate informed, effective and intelligent business strategies and ensure their leadership in the market.

Media Contact : 

Company Name: Claight Corporation
Contact Person: Louis Wane, Corporate Sales Specialist – U.S.A.
Toll Free Number: +1-415-325-5166 | +44-702-402-5790
Address: 30 North Gloud Street, Sheridan, WY 82801, USA


Olivia Jones is a passionate writer and WordPress user dedicated to sharing insightful news and media articles. With a deep interest in current affairs and a knack for storytelling, she strives to provide readers with well-researched, engaging, and informative content. Olivia Jones leverages the platform's versatility to create visually appealing and user-friendly articles. [He/She] understands the importance of delivering content in a format that is accessible and engaging for readers from diverse backgrounds.

Write A Comment